Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Methotrexate, formerly known as amethopterin, is a chemotherapy agent and immune-system suppressant. It is used to treat cancer, autoimmune diseases, and ectopic pregnancies. It is used for cancers such as breast cancer, leukemia, lung cancer, lymphoma, gestational trophoblastic disease, and osteosarcoma, as well as autoimmune diseases such as psoriasis…
The analysis highlights History and Applications as prominent areas in the source structure around Methotrexate.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Methotrexate shows recurring relationship patterns in the source. For example, Methotrexate → Animal, In, Jane, Lederle, Min Chiu Li, Other, Sidney Farber, The, Wright, Wright's, Yellapragada Subbarao Another extracted example is Methotrexate → GI, Likewise, Nitrous, NSAIDs, Other, Penicillins, Probenecid, The, While. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
used effects cancer treatment arthritis acid rheumatoid doses may drug use side folic disease lower autoimmune also toxicity risk treat
TTTA extracted 117 structured relationships around Methotrexate. Examples in this analysis include Methotrexate → 3D model (JSmol) → Interactive image and Methotrexate → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Methotrexate | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Methotrexate | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Methotrexate | ATC code | L01BA01 (WHO) L04AX03 (WHO) | 1.00 | infobox |
| Methotrexate | Bioavailability | 60% at lower doses, less at higher doses. | 1.00 | infobox |
| Methotrexate | CAS Number | 59-05-2 Y | 1.00 | infobox |
| Methotrexate | ChEBI | CHEBI:44185 Y | 1.00 | infobox |
| Methotrexate | ChEMBL | ChEMBL34259 Y | 1.00 | infobox |
| Methotrexate | ChemSpider | 112728 Y | 1.00 | infobox |
| Methotrexate | CompTox Dashboard (EPA) | DTXSID4020822 | 1.00 | infobox |
| Methotrexate | DrugBank | DB00563 Y | 1.00 | infobox |
| Methotrexate | ECHA InfoCard | 100.000.376 | 1.00 | infobox |
| Methotrexate | Elimination half-life | 3–10 hours (lower doses), 8–15 hours (higher doses) | 1.00 | infobox |
| Methotrexate | Excretion | Urine (80–100%), feces (small amounts) | 1.00 | infobox |
| Methotrexate | Formula | C20H22N8O5 | 1.00 | infobox |
| Methotrexate | IUPHAR/BPS | 4815 | 1.00 | infobox |
| Methotrexate | KEGG | D00142 Y | 1.00 | infobox |
| Methotrexate | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Methotrexate | Legal status | CA: ℞-only | 1.00 | infobox |
| Methotrexate | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Methotrexate | Legal status | US: ℞-only | 1.00 | infobox |
| Methotrexate | Legal status | EU: Rx-only | 1.00 | infobox |
| Methotrexate | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Methotrexate | License data | US DailyMed: Methotrexate | 1.00 | infobox |
| Methotrexate | MedlinePlus | a682019 | 1.00 | infobox |
| Methotrexate | Metabolism | Hepatic and intracellular | 1.00 | infobox |
| Methotrexate | Molar mass | 454.447 g·mol−1 | 1.00 | infobox |
| Methotrexate | Other names | MTX, amethopterin | 1.00 | infobox |
| Methotrexate | PDB ligand | MTX (PDBe, RCSB PDB) | 1.00 | infobox |
| Methotrexate | Pregnancy category | AU: D | 1.00 | infobox |
| Methotrexate | Pronunciation | /ˌmɛθəˈtrɛkˌseɪt, ˌmiː-, -θoʊ-/ ⓘ | 1.00 | infobox |
The concept neighborhoods around Methotrexate bring nearby vocabulary together. In this analysis, examples include Used, Treatment and Rheumatoid. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Methotrexate, one of the stronger structural bridges in this analysis connects Methotrexate with Medical uses. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Methotrexate to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History & Applications, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Methotrexate · EN edition · Analysis: TopicsToTalkAbout